KRIBB11

Discontinued Product

5480 has been discontinued.

View all Hsp90 products.
说明: HSF1 inhibitor
化学名: N2-1H-Indazol-5-yl-N6-methyl-3-nitro-2,6-pyridinediamine
纯度: ≥99% (HPLC)
说明书
引用文献
评论
文献 (2)

生物活性 for KRIBB11

KRIBB11 is a heat shock factor (HSF) inhibitor (IC50 = 1.2 μM). Increases apoptosis in cancer cells treated with the HSP90 inhibitors Geldanamycin (Cat. No. 1368) and 17-AAG (Cat. No. 1515). Blocks downstream induction of HSP27 and HSP70. Inhibits tumor growth in vivo.

技术数据 for KRIBB11

分子量 284.27
公式 C13H12N6O2
储存 Store at -20°C
纯度 ≥99% (HPLC)
CAS Number 342639-96-7
PubChem ID 69894253
InChI Key NDJJEQIMIJJCLL-UHFFFAOYSA-N
Smiles CNC1=NC(NC2=CC=C(NN=C3)C3=C2)=C([N+]([O-])=O)C=C1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

关键词: KRIBB11, KRIBB11 supplier, HSF1, inhibitors, inhibits, heat, shock, factors, 1, HSP90, HSP70, HSP27, proteins, Hsp90, Hsp70, Other, Transcription, Factors, 5480, Tocris Bioscience

篇 KRIBB11 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 KRIBB11 的引用文献。

KRIBB11 的评论

目前没有该产品的评论。 Be the first to review KRIBB11 and earn rewards!

Have you used KRIBB11?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Cell Cycle and DNA Damage Research Product Guide

Cell Cycle and DNA Damage Research Product Guide

This product guide provides a review of the cell cycle and DNA damage research area and lists over 150 products, including research tools for:

  • Cell Cycle and Mitosis
  • DNA Damage Repair
  • Targeted Protein Degradation
  • Ubiquitin Proteasome Pathway
  • Chemotherapy Targets
Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.